Combined therapy with probiotic VSL#3 and Omega-3 fatty acids attenuates colonic injury and inflammation in chronic DNBS-induced colitis in mice
Göster/ Aç
Erişim
info:eu-repo/semantics/openAccessTarih
2022Yazar
Yoldaş İlktaç, HavvanurKızıltan, Gül
Lanpir, Aslı Devrim
Ozansoy, Mehmet
Günal, Mehmet Yalçın
Özmen Togay, Sine
Keskin, İlknur
Özdemir, Ekrem M.
Kılıç, Ulkan
Üst veri
Tüm öğe kaydını gösterÖzet
We published the abovementioned article about probiotic mixture VSL#3 on
October 6, 2021. Since the product was named VSL#3 in our purchasing
process in early 2016, it is referred to as VSL#3 in our article. In addition, the
product currently known as VSL#3 is not the same as De Simone Formulation.
De Simone Formulation is now available as Visbiome® in the United States
and Vivomixx® in Europe. The authors would like to apologise for any
inconvenience caused
Kaynak
Folia Biologica-KrakowCilt
70Sayı
1Bağlantı
https://hdl.handle.net/20.500.12868/1557https://www.webofscience.com/wos/woscc/full-record/WOS:000713193000004